BIOINVENT FINANCIAL STATEMENT 1 JANUARY-31 DECEMBER 2003
BIOINVENT FINANCIAL STATEMENT 1 JANUARY-31 DECEMBER 2003 * Promising pre-clinical data for BioInvent's HIV project: The Company's antibodies against HIV are effectively preventing the spread of the virus between human cells. * Progress within BioInvent's atherosclerosis treatment project: Antibodies tested in pre-clinical animal models indicate a clear reduction in plaque in the blood vessels. * Project portfolio strengthened: Drug projects initiated for the treatment of widespread diseases such as cancer and osteoarthritis according to new therapeutic principles. * Cross-licensing agreement regarding antibody technologies signed with XOMA, a US pharmaceutical company. * Patent portfolio strengthened: European patent granted for the n-CoDeR antibody library. * Net revenues for January - December 2003: SEK 66.7 million (87.1) * Cash flow from current operations and investment activities for January - December 2003: SEK -75.5 million (-47.1). Liquid funds at the end of the year: SEK 268.5 million (343.6). * Loss after net financial items for January - December 2003 amounted to SEK -89.7 million (-46,2) and the loss after net financial items per share was SEK -3.04 (1.60). Contact: Any questions regarding this report will be answered by: Svein Mathisen, President & CEO, tel.+46 (0)46 286 85 67, mobile +46 (0)708 97 82 13 or Cristina Glad, Executive Vice President, +46 (0)46 286 85 51, mobile +46 (0)708 16 85 70. The report is also available at www.bioinvent.com BioInvent International AB (publ.) Co. reg. no. 556537-7263 Address: Sölvegatan 41, 223 70 Lund Tel.: +46 (0)46 286 85 50 info@bioinvent.com www.bioinvent.com Legal disclaimer This press release contains statements relating to future scenarios. Research and development activity within the biotech field is associated with risk and/or uncertainty. With this in mind, the actual outcome may deviate significantly from what is described in this press release. ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2004/06/02/20040602BIT00370/wkr0001.doc The full report http://www.waymaker.net/bitonline/2004/06/02/20040602BIT00370/wkr0002.pdf The full report